These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 9927308)

  • 1. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta.
    Sun J; Meyers MJ; Fink BE; Rajendran R; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 1999 Feb; 140(2):800-4. PubMed ID: 9927308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
    Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
    Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
    Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
    Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.
    Shiau AK; Barstad D; Radek JT; Meyers MJ; Nettles KW; Katzenellenbogen BS; Katzenellenbogen JA; Agard DA; Greene GL
    Nat Struct Biol; 2002 May; 9(5):359-64. PubMed ID: 11953755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
    Harrington WR; Sheng S; Barnett DH; Petz LN; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Cell Endocrinol; 2003 Aug; 206(1-2):13-22. PubMed ID: 12943986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of estrogen-responsive element- and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ER alpha and ER beta.
    Yi P; Driscoll MD; Huang J; Bhagat S; Hilf R; Bambara RA; Muyan M
    Mol Endocrinol; 2002 Apr; 16(4):674-93. PubMed ID: 11923465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding.
    Zhu BT; Han GZ; Shim JY; Wen Y; Jiang XR
    Endocrinology; 2006 Sep; 147(9):4132-50. PubMed ID: 16728493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha.
    Larrea F; García-Becerra R; Lemus AE; García GA; Pérez-Palacios G; Jackson KJ; Coleman KM; Dace R; Smith CL; Cooney AJ
    Endocrinology; 2001 Sep; 142(9):3791-9. PubMed ID: 11517155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
    Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
    Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor-dependent and -independent pathways.
    Xia Y; Xing JZ; Krukoff TL
    Neuroscience; 2009 Aug; 162(2):292-306. PubMed ID: 19410635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner.
    Ramsey TL; Risinger KE; Jernigan SC; Mattingly KA; Klinge CM
    Endocrinology; 2004 Jan; 145(1):149-60. PubMed ID: 14500565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
    Kuiper GG; Lemmen JG; Carlsson B; Corton JC; Safe SH; van der Saag PT; van der Burg B; Gustafsson JA
    Endocrinology; 1998 Oct; 139(10):4252-63. PubMed ID: 9751507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonists selective for estrogen receptor alpha.
    Sun J; Huang YR; Harrington WR; Sheng S; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 2002 Mar; 143(3):941-7. PubMed ID: 11861516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of peptide antagonists that target estrogen receptor beta-coactivator interactions.
    Hall JM; Chang CY; McDonnell DP
    Mol Endocrinol; 2000 Dec; 14(12):2010-23. PubMed ID: 11117531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.